Cancer Vaccines
Findings in cancer vaccines provide new insights
Published in Vaccine Weekly, May 11th, 2005
Study 1: Researchers report the impact of p53-based immunization on primary chemically-induced tumors in a recent issue of the International Journal of Cancer.
According to a study from the United States, "In mice as well as humans, cytotoxic T lymphocytes (CTL) specific for wild-type-sequence (wt) p53 peptides have been shown to react against a wide range of tumors, but not normal cells. As such, they are attractive candidates for developing broadly applicable cancer vaccines. Of particular interest is the potential of using p53-based vaccines in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-05-11)
More Articles from Vaccine Weekly
- Alzheimer Disease
Anti-A beta antibody isotypes effective against A-beta in TgCRND8 brain - Influenza Vaccine
Inactivated influenza vaccine prevents influenza in diabetic mice - Streptococcus Vaccine
Leucine-rich repeat protein antigen from streptococci elicits immunity - Tuberculosis Vaccine
Prescreening program tested a wide range of tuberculosis vaccines - Vaccine Development
Visualization of B-cell response aids selection of vaccine immunogens - Anticancer Therapy
Hsp90 activation and cell cycle regulation discussed - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
